4.8 Article

Electrochemical immunoassay for carcinoembryonic antigen based on signal amplification strategy of nanotubular mesoporous PdCu alloy

期刊

BIOSENSORS & BIOELECTRONICS
卷 36, 期 1, 页码 6-11

出版社

ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2012.02.064

关键词

Label-free immunosensor; Hollow nanostructure; Graphene; Carcinoembryonic antigen; Thionine

资金

  1. Natural Science Foundation of China [21075052, 21175057, 51005103]
  2. Natural Science Foundation of Shandong Province [ZR2010BM030, ZR2010ZR063]
  3. Science and Technology Key Plan Project of Shandong Province [2010GSF10628]
  4. Special Research and Development Environmental Protection Industry of Shandong Province
  5. National Major Projects on Water Pollution Control and Management Technology [2008ZX07422]
  6. Science and Technology Development Plan Project of Jinan City [201004015]

向作者/读者索取更多资源

Interests in using nanoporous metals for biosensing applications have been increasing. Herein, nanotubular mesoporous PdCu (NM-PdCu) alloy is used to fabricate a novel label-free electrochemical immunosensor for cancer biomarker carcinoembryonic antigen (CEA). It operates through physisorption of anti-CEA on NM-PdCu and the mixture of sulfonated graphene sheets (HSO3-GS) and thionine (TH) functionalized glassy carbon electrode interface as the detection platform. In this study, chitosan (CS)-PdCu is bound very strongly to carcinoembryonic antibody (anti-CEA), because of the good electron conductivity, high surface area, and good biocompatibility. CS-PdCu is immobilized on electrodes by electrostatic interactions between the negatively charged sulfo group of HSO3-GS and the abundant positively charged amino groups of chitosan. TH acts as the redox probe. Under the optimized conditions, the electrochemical immunosensor exhibits a wide working range from 0.01 to 12 ng/mL with a low detection limit of 4.86 pg/mL. The accuracy, reproducibility, and stability of the immunosensor are acceptable. The assay is evaluated for real serum samples, receiving satisfactory results. The nanoporous metal materials-based immunoassay provides a promising approach in clinical application and thus represents a versatile detection method. (C) 2012 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据